Fine-tune your coding sequences with VectorBee 3.0.
Choose CDS translation, select reading frames, display labels on vector and sequence maps, and preview predicted protein size.
π Try VectorBee, forever free: www.vectorbee.com/en/
Fine-tune your coding sequences with VectorBee 3.0.
Choose CDS translation, select reading frames, display labels on vector and sequence maps, and preview predicted protein size.
π Try VectorBee, forever free: www.vectorbee.com/en/
Why does lentivirus remain one of the most widely used gene delivery platforms? π§¬
In our upcoming Gene Delivery Seminar, youβll learn about the features that make lentiviral vectors so effective and how you can optimize them for your research.
Register here: us06web.zoom.us/webinar/regi...
Work with your enzymes, your way.
Quickly identify restriction sites for selected enzymes using the new Enzyme List Visualization feature and run more interactive gel simulations in VectorBee 3.0
π Try VectorBee, forever free: www.vectorbee.com/en/
π Try VectorBee, forever free: www.vectorbee.com/en/
Experience the smoothest sequence alignments with VectorBee 3.0.
You can now edit chromatogram samples directly within alignment projects, with improved visualization and chromatogramβsequence interaction. Plus expanded import options, alignment draft saving, and sample information editing.
Dr. Jorge Batista Da Rocha ( @ensembl.org ) will demonstrate how researchers can access, explore, and analyze genomic data using the Ensembl genome browser, while Dr. Jen Kong (VectorBuilder) will show how those genomic insights can translate directly into practical vector design using VectorBee.
Join us at the Midwest CRISPR Animal Modeling Symposium (M-CAMS 2026) for a training session on connecting genomic discovery with vector design.
Designing, editing, annotating, and analyzing vectors shouldnβt feel like juggling. VectorBee 3.0βs refreshed interface makes switching between project panels easier than ever - clean, simple, and intuitive.
π Try VectorBee, forever free: www.vectorbee.com/en/
π Try VectorBee, forever free: www.vectorbee.com/en/
Work your magic with VectorBee 3.0 β meet the Vector Design Wizard. π
Vector design just got easier. With only a few clicks, the Vector Design Wizard lets you create vectors, annotate sequences, run analyses, and place your order all in one place!
Are AAVs dead - or do LNPs still have a way to go?
If youβre at the Royal College of Surgeons ( @rcsi.bsky.social ) in Ireland this Wednesday, join Dr. Alan Griffith as he breaks down the strengths and limitations of AAV and LNP gene delivery platforms.
Going to ELRIG's Cell and Gene Therapy Conference? π§¬
Our team will be excited to connect at Cell & Gene Therapy 2026 in Cambridge. Stop by our Booth #9 and chat to one of our team members to learn about our latest offerings and solutions for your CGT research. See you there!
Because accelerating your discoveries shouldnβt come with a price tag.
π Try it out here, forever free: vectorbee.com/en/
π Weβre excited to introduce VectorBee 3.0, with over 17 new and optimized features for vector design and molecular biology analysis. And the best part: itβs still forever free!
These improvements will streamline your workflows, giving you more time to focus on the research that matters.
Our application scientist, Dr. Skye Storrie, will examine the key attributes that make lentivirus a powerful and widely used gene delivery platform and share practical strategies to enhance your vector production and efficacy.
Register here: us06web.zoom.us/webinar/regi...
𧬠What makes lentivirus such a powerful gene delivery tool?
Join our next Gene Delivery Seminar to learn how you can optimize lentiviral vectors for stronger performance in your research and clinical applications.
Learn more about our lentivirus packaging options for in vitro and in vivo gene delivery here: en.vectorbuilder.com/products-ser...
Excited to highlight recent work from the Romain Loyon lab exploring TCR-based strategies to target the oncogene SALL4 in solid tumors.
Engineered T cells reduced tumor growth in preclinical models, supporting further development of precision T cell therapies for cancer.
Learn more about our shRNA gene knockdown solutions here: en.vectorbuilder.com/products-ser...
Looking to streamline your RNAi workflow?
Our shRNA platform supports intuitive design, flexible delivery, and stable knockdown: silence genes and amplify your results.
Sequence-guaranteed, fast turnaround, and dedicated technical support.
March is Colorectal Cancer, Kidney Cancer, Multiple Myeloma, and Endometriosis Awareness Month.
Behind every diagnosis is a patient who deserves better treatments and outcomes.
At VectorBuilder, we support scientists advancing earlier detection and novel therapies so breakthroughs reach patients.
On #RareDiseaseDay, we recognize the 300+ million people worldwide living with a rare disease. Most of these conditions still lack approved treatments, leaving patients with limited options.
At VectorBuilder, we support researchers advancing new therapies and stand with the rare disease community.
Thanks for bringing this to our attention. We are looking into this matter immediately, and deepest apologies for the inconvenience!
Marching into the next month of 2026 βοΈ
Don't miss the VectorBuilder team at the next key conferences!
Excited to see you there!
See the full video on our YouTube channel here: youtu.be/QkwMBufVhSs?...
Interested in using tissue-clearing techniques to study intact samples in 3D? Check out our seminar with Dr. @cristina-mtz-glz.bsky.social as she introduces novel tissue-clearing strategies and key considerations for selecting the right protocol for different samples and research objectives.
Have you heard of LentiBuilderβ’? Level up your lentivirus production.
β
Ultra-high titers, even with oversized genomes
β
Powerful transduction, even in complex cells
β
Minimal steps, maximum expression
See what our customers are saying.
𧬠Happening today! Join our Gene Delivery Seminar to learn how disease models are used to study early genetic events in vivo and what they reveal about how disease begins. Register now!
Excited to highlight new work from the @roychoudhurilab.bsky.social showing control of BACH2 dosage can improve adoptive T cell therapies.
Low-dose BACH2 promotes T cell persistence without compromising effector function, enhancing antitumor activity. A step forward for personalized immunotherapy.
Still looking for a card for tomorrow?
Free downloadable geeky Valentineβs, right this way π§ͺπ
Download here: hubs.la/Q041jHGJ0